No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use

Life Sciences - Tập 66 - Trang 1079-1083 - 2000
Gary L. Wenk1, Guenter Quack2, Hans-Joerg Moebius2, Wojciech Danysz2
1Arizona Research Laboratories Division of Neural Systems, Memory & Aging, University of Arizona, Tucson, Arizona, USA
2Department of Pharmacology, MERZ + Co. GmbH & Co., D-60318 Frankfurt/Main, Germany

Tài liệu tham khảo

Perry, 1978, Br. Med. J., 2, 1456, 10.1136/bmj.2.6150.1457 Farlow, 1992, JAMA, 268, 2523, 10.1001/jama.268.18.2523 Rogers, 1998, Arch. Int. Med., 158, 1021, 10.1001/archinte.158.9.1021 Wenk, 1997, Neurobiol. Learn. Mem., 67, 85, 10.1006/nlme.1996.3757 Greenamyre, 1989, Neurobiol. Aging, 10, 593, 10.1016/0197-4580(89)90143-7 Parsons, 1999, Neuropharmacol., 38, 735, 10.1016/S0028-3908(99)00019-2 Gortelmeyer, 1992, Arzeneim-Forsch/Drug Res., 42, 904 Winblad, 1999, Int. J. Geriat. Psychiatry, 14, 135, 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0 Kornhuber, 1991, Eur. J. Pharmacol., 206, 297, 10.1016/0922-4106(91)90113-V Gupta, 1989, J. Toxicol. Environ. Hlth., 28, 111, 10.1080/15287398909531332 Gupta, 1991, Drug Dev. Res., 24, 329, 10.1002/ddr.430240404 Mclean, 1992, Toxicol. Appl. Pharmacol., 112, 95, 10.1016/0041-008X(92)90284-Y Galli, 1996, J. Pharm. Pharmacol., 48, 71, 10.1111/j.2042-7158.1996.tb05881.x Ellman, 1961, Biochem. Pharmacol., 7, 88, 10.1016/0006-2952(61)90145-9 Barnes, 1996, Eur. J. Neurosci., 8, 65, 10.1111/j.1460-9568.1996.tb01241.x Zajaczkowski, 1997, Neuropharm., 36, 961, 10.1016/S0028-3908(97)00070-1